triazolam/temazepam

1
Reactions 436 - 30 Jan 1993 Triazolam/temazepam Behavioural disturbances: incidence study A review of the records at McLean Hospital, Massachussetts, USA, revealed no significant difference between the incidence of behavioural disturbances in psychiatric inpatients who received triazolam (n = 72) or temazepam (112). Author comment: ‘We did not find that triazolam had unique disinhibitory activity.’ Editorial Comment: The results of a survey published recently in the Lancet showed that agents given as substitutes for triazolam following the withdrawal of the latter were not necessarily associated with fewer adverse effects (see Reactions 435: 2, 23 Jan 1992) Rothschild AJ, et al. Triazolam and disinhibition. Lancet 341: 186, 16 Jan 1993 - USA 800176681 » Editorial comment: The results of a survey published recently in the Lancet showed that agents given as substitutes for triazolam following the withdrawal of the latter were not necessarily associated with fewer adverse effects [see Reactions 435: 2, 23 Jan 1992]. 1 Reactions 30 Jan 1993 No. 436 0114-9954/10/0436-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: ngoanh

Post on 19-Mar-2017

218 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Triazolam/temazepam

Reactions 436 - 30 Jan 1993

Triazolam/temazepam

Behavioural disturbances: incidence studyA review of the records at McLean Hospital,

Massachussetts, USA, revealed no significant differencebetween the incidence of behavioural disturbances inpsychiatric inpatients who received triazolam (n = 72) ortemazepam (112).

Author comment: ‘We did not find that triazolam hadunique disinhibitory activity.’ Editorial Comment: The resultsof a survey published recently in the Lancet showed thatagents given as substitutes for triazolam following thewithdrawal of the latter were not necessarily associated withfewer adverse effects (see Reactions 435: 2, 23 Jan 1992)Rothschild AJ, et al. Triazolam and disinhibition. Lancet 341: 186, 16 Jan 1993 -USA 800176681

» Editorial comment: The results of a survey published recentlyin the Lancet showed that agents given as substitutes fortriazolam following the withdrawal of the latter were notnecessarily associated with fewer adverse effects [see Reactions435: 2, 23 Jan 1992].

1

Reactions 30 Jan 1993 No. 4360114-9954/10/0436-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved